Shalby Ltd - 540797 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on March 31, 2022.09-04-2022
09-04-2022
Shalby Ltd - 540797 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- Tushar ShahDesignation :- Company Secretary and Compliance Officer09-04-2022
Meet the Jabalpur man with the rarest of blood groups Ael'
Shalby Hospital in Ahmedabad identified the blood group of the donor the first documented case in India06-04-2022
Shalby Ltd - 540797 - Closure of Trading Window
In terms of the provisions of sub-regulation (1) of Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and trading restrictions placed by the Company''s Code of Conduct to Regulate, Monitor and Reporting of Trading by Insiders ("The Code"), we wish to inform you that window for trading in securities of the Company will remain closed from April 01, 2022 till the expiry of 48 hours after the declaration of the Audited Financial Results for the Financial year and quarter ended March 31, 2022 and the trading window shall re-open thereafter. According to the Insider Trading Code of the Company, all Insiders of the Company have been advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window.30-03-2022
Shalby Ltd - 540797 - Further Subscription By Mars Medical Devices Limited In Shalby Global Technologies Pte. Ltd., Singapore
Further Subscription of 3,50,000 equity shares of SGD 1 by Mars Medical Devices Limited In Shalby Global Technologies Pte. Ltd., Singapore25-03-2022
Shalby Ltd - 540797 - Change Of Name Of Registrar & Transfer Agent From Kfin Technologies Private Limited To Kfin Technologies Limited
Change of name of Registrar & Transfer Agent from Kfin Technologies Private Limited to Kfin Technologies Limited19-03-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30(6) of SEBI (LODR) Regulations, 2015- Participation in Centrum - Hospitals and Diagnostics day conclave on 16th March, 2022.14-03-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30(6) of SEBI (LODR) Regulations, 2015- Investor Meeting on 14th March, 2022.14-03-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Inauguration of Shalby Orthopedics Centre of Excellence (SOCE) in Ahmedabad and Celebration of 28th Anniversary13-03-2022
Shalby Ltd - 540797 - Receipt Of Import License For Import Of Medical Devices To Wholly-Owned Subsidiary Company Mars Medical Devices Limited
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are pleased to announce that our Wholly-Owned subsidiary Company M/s. Mars Medical Devices Limited, has received Import License from Central Drugs Standard Control Organization, Ministry of Health and Family Welfare, Govt. of India, for import of Medical Devices for the Complete range of Joint replacement products i.e. Total Knee System, Total Hip System etc. from M/s Shalby Advanced Technologies Inc. USA (Step-down subsidiary of the Company) today.09-02-2022